ALC (Alcon Inc.) Earnings growth in current year

ALC (Alcon Inc.) - company brandmark

Surgeons' loyalty to Alcon Inc. (ALC) equipment creates a steady revenue stream from consumables. This annual EPS growth chart illustrates this trend, where the value 13.70 shows the current figure. Robotic lens assembly lines guarantee sterility. Simultaneously, R&D centers are implementing AI microscopes and smart optics, ensuring technological leadership in the ophthalmology segment.

ALC: Alcon Vision Earnings growth in current year 07/04/2022 - 11/11/2026

Analytical breakdowns and data insights for company Alcon Inc. (ALC)

- current quotes and average value forecast:
Market Chart Alcon Inc|ALC - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Alcon Corp|ALC - Total Company Value
- book capitalization data:
Net Assets per Single Share Alcon|ALC - Book Capitalization|Market Cap to Net Assets Ratio alcon.com|ALC - Aggregate Company Assets
- debt and liquidity details:
Debt to Capital Alcon Inc.|ALC - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio alcon.com|ALC - Company Total Debt|Debt to Net Assets Ratio Alcon Corp|ALC - Company Long-Term Debts|Short-Term Debt Volume Alcon|Immediate Liquidity Ratio alcon.com
- earnings and valuation multiples information:
ALC - Net Profit|Future Profit Alcon Inc.|ALC - Price to Earnings Ratio|Market Cap to Projected Earnings Alcon Corp|ALC - PEG Multiple|EV/EBITDA Multiple Alcon Corp|ALC - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Alcon|ALC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months alcon.com|ALC - Earnings per share growth in current year|Net earnings per share change forecast for next year Alcon Inc.
Summary company analysis:Alcon Inc (ALC)
Signature product of Alcon Inc

Alcon Inc. implementation of lens recycling systems and closed-loop water circuits requires capital expenditures that impact net income. The annual EPS range dynamics, which reached 13.70, measure the percentage increase in earnings per share relative to the previous year, allowing investors to assess the efficiency of the operating model and the risk of capital value stagnation should growth rates slow.

Direct competitors

BLCO - Expected net earnings per share growth this year|GKOS (Glaukos Corp.) - Earnings growth in current year|Earnings growth in current year Apellis Corp|Earnings per share growth in current year Belite Bio (BLTE)|Earnings per share growth in current year OCUL (ocutx.com)|Earnings growth in current year HROW (Harrow)|VRDN - Net earnings per share growth this year|LENZ - Earnings per share growth in current year|Earnings per share growth rate in current year Oaktree Specialty Lending|EyePoint Pharmaceuticals (EYPT) - Earnings per share growth in current year|Earnings per share growth this year KOD|Net earnings per share growth this year ALDX|KALA: Earnings per share increase in current year|Earnings growth in current year IRD|Expected net earnings per share growth this year okyopharma.com|Earnings per share growth in current year Adverum Biotechnologies, Inc. ADVM|OTLK: Earnings per share growth this year|Clearside Biomedical, Inc. - Earnings growth in current year|NovaBay Pharmaceuticals (NBY) - Net earnings per share growth this year|KPRX (kiorapharma.com) - Net earnings per share growth this year|ALIM - Expected net earnings per share growth this year|EYEN (Eyenovia Inc.) - Earnings growth in current year|Earnings growth in current year guardionhealth.com|Earnings per share growth in current year Ocuphire Pharma (OCUP)|Earnings per share growth in current year OPT (Opthea Ltd)